← Back to Patent Explorer
US4044125A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of stabilizing acetylsalicylic acid in the presence of d-propoxyphene hydrochloride and compositions thereof

Assignee: Eli Lilly and Co
•
Filing: 1976-03-22
•
Granted: 1977-08-23
•
Expires: 1996-03-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method of inhibiting the hydrolysis of acetylsalicyclic acid in the presence of d-propoxyphene hydrochloride in pharmaceutical compositions comprising admixing the hydrochloride of one of the 23 naturally occuring amino acids therewith, and compositions containing such amino acid hydrochloride, acetylsalicylic acid and d-propoxyphene hydrochloride.

Inventors

  • 👤 Walter D. Walkling

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:45
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/60; A61K31/618; A61K31/621; A61K47/00; A61K47/06; A61K47/16; A61K47/18; A61K47/183

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 49 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising actylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating glutamic acid hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 2
Independent Claim 49 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising actylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating glutamic acid hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 3
Independent Claim 48 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating lysine dihydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 4
Independent Claim 48 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating lysine dihydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 5
Independent Claim 48 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating glycine hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 6
Independent Claim 48 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating glycine hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 7
Independent Claim 48 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating alanine hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 8
Independent Claim 48 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating alanine hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 9
Independent Claim 49 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating aspartic acid hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.
Claim 10
Independent Claim 49 words
The method of inhibiting the hydrolysis of acetylsalicylic acid in a pharmaceutical composition comprising acetylsalicylic acid and d-propoxyphene hydrochloride which comprises incorporating aspartic acid hydrochloride into such pharmaceutical composition in an amount of from about 5 to about 130 percent by weight of d-propoxyphene hydrochloride in such pharmaceutical composition.

References Cited (Backward Citations)

US2101867A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-08-22 1981-02-21 1981-08-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-08-22 1985-02-21 1985-08-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-08-22 1989-02-21 1989-08-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag